Impact of Regional Nodal Irradiation for Breast Cancer Patients with Supraclavicular and/or Internal Mammary Lymph Node Involvement: A Multicenter, Retrospective Study (KROG 16-14)
1
조회
0
다운로드
2
인용
0
참고문헌
키워드
초록
Purpose The purpose of this study was to evaluate the treatment outcomes of radiotherapy (RT) for breast cancer with ipsilateral supraclavicular (SCL) and/or internal mammary (IMN) lymph node involvement. Materials and Methods A total of 353 patients from 11 institutions were included. One hundred and thirty-six patients had SCL involvement, 148 had IMN involvement, and 69 had both. All patients received neoadjuvant systemic therapy followed by breast-conserving surgery or mastectomy, and postoperative RT to whole breast/chest wall. As for regional lymph node irradiation, SCL RT was given to 344 patients, and IMN RT to 236 patients. The median RT dose was 50.4 Gy. Results The median follow-up duration was 61 months (range, 7 to 173 months). In-field progression was present in SCL (n=20) and/or IMN (n=7). The 5-year disease-free survival (DFS) and overall survival rates were 57.8% and 75.1%, respectively. On multivariate analysis, both SCL/IMN involvement, number of axillary lymph node 4, triple-negative subtype, and mastectomy were significant adverse prognosticators for DFS (p=0.022, p=0.001, p=0.001, and p=0.004, respectively). Regarding the impact of regional nodal irradiation, SCL RT dose 54 Gy was not associated with DFS (5-year rate, 52.9% vs. 50.9%; p=0.696) in SCLinvolved patients, and the receipt of IMN RT was not associated with DFS (5-year rate, 56.1% vs. 78.1%; p=0.099) in IMN-involved patients. Conclusion Neoadjuvant chemotherapy followed by surgery and postoperative RT achieved an acceptable in-field regional control rate in patients with SCL and/or IMN involvement. However, a higher RT dose to SCL or IMN RT was not associated with the improved DFS in these patients.
Abstract
Purpose The purpose of this study was to evaluate the treatment outcomes of radiotherapy (RT) for breast cancer with ipsilateral supraclavicular (SCL) and/or internal mammary (IMN) lymph node involvement. Materials and Methods A total of 353 patients from 11 institutions were included. One hundred and thirty-six patients had SCL involvement, 148 had IMN involvement, and 69 had both. All patients received neoadjuvant systemic therapy followed by breast-conserving surgery or mastectomy, and postoperative RT to whole breast/chest wall. As for regional lymph node irradiation, SCL RT was given to 344 patients, and IMN RT to 236 patients. The median RT dose was 50.4 Gy. Results The median follow-up duration was 61 months (range, 7 to 173 months). In-field progression was present in SCL (n=20) and/or IMN (n=7). The 5-year disease-free survival (DFS) and overall survival rates were 57.8% and 75.1%, respectively. On multivariate analysis, both SCL/IMN involvement, number of axillary lymph node 4, triple-negative subtype, and mastectomy were significant adverse prognosticators for DFS (p=0.022, p=0.001, p=0.001, and p=0.004, respectively). Regarding the impact of regional nodal irradiation, SCL RT dose 54 Gy was not associated with DFS (5-year rate, 52.9% vs. 50.9%; p=0.696) in SCLinvolved patients, and the receipt of IMN RT was not associated with DFS (5-year rate, 56.1% vs. 78.1%; p=0.099) in IMN-involved patients. Conclusion Neoadjuvant chemotherapy followed by surgery and postoperative RT achieved an acceptable in-field regional control rate in patients with SCL and/or IMN involvement. However, a higher RT dose to SCL or IMN RT was not associated with the improved DFS in these patients.
참고문헌 (15)
- Poortmans PM, "Internal mammary and medial supraclavicular irradiation in breast cancer", N Engl J Med, 373, pp.317~327 (2015)
- Whelan TJ, "Regional nodal irradiation in early-stage breast cancer", N Engl J Med, 373, pp.307~316 (2015)
- Park HJ, "Outcomes of positron emission tomography-staged clinical N3breast cancer treated with neoadjuvant chemotherapy, surgery, and radiotherapy", Int J Radiat Oncol Biol Phys, 81, pp.e689~e695 (2011)
- Huang EH, "Locoregional treatment outcomes for breast cancer patients with ipsilateral supraclavicular metastases at diagnosis", Int J Radiat Oncol Biol Phys, 67, pp.490~496 (2007)
- Zhang YJ, "Clinically apparent internal mammary nodal metastasis in patients with advanced breast cancer : incidence and local control", Int J Radiat Oncol Biol Phys, 77, pp.1113~1119 (2010)
- Anderson TL, "Cross-sectional imaging to evaluate the extent of regional nodal disease in breast cancer patients undergoing neoadjuvant systemic therapy", Eur J Radiol, 89, pp.163~168 (2017)
- Wang CL, "(18)F-FDG PET", CT-positive internal mammary lymph nodes : pathologic correlation by ultrasound-guided fine-needle aspiration and assessment of associated risk factors, 2013, pp.200, 1138~1144
- Iyengar P, "The value of ultrasound in detecting extra-axillary regional node involvement in patients with advanced breast cancer", Oncologist, 17, pp.1402~1408 (2012)
- Chen RC, "Internal mammary nodes in breast cancer : diagnosis and implications for patient management : a systematic review", J Clin Oncol, 26, pp.4981~4989 (2008)
- Lacour J, "Radical mastectomy versus radical mastectomy plus internal mammary dissection. Ten year results of an international cooperative trial in breast cancer", Cancer, 51, pp.1941~1943 (1983)
- Veronesi U, "The dissection of internal mammary nodes does not improve the survival of breast cancer patients. 30-year results of a randomised trial", Eur J Cancer, 35, pp.1320~1325 (1999)
- 정진홍, "Treatment Outcome of Breast Cancer with Pathologically Proven Synchronous Ipsilateral Supraclavicular Lymph Node Metastases", Journal of Breast Cancer, 18(2), pp.167~172 (2015), 한국유방암학회
- Chang XZ, "A retrospective study of different local treatments in breast cancer patients with synchronous ipsilateral supraclavicular lymph node metastasis", J Cancer Res Ther, 9(Suppl), pp.S158~S161 (2013)
- Noh JM, "Prognostic significance of nodal involvement region in clinical stage IIIc breast cancer patients who received primary systemic treatment, surgery, and radiotherapy", Breast, 24, pp.637~641 (2015)
- Joo JH, "Impact of pathologic diagnosis of internal mammary lymph node metastasis in clinical N2b and N3b breast cancer patients", Breast Cancer Res Treat, 166, pp.511~518 (2017)